ChemoMetec Balance Sheet Health
Financial Health criteria checks 6/6
ChemoMetec has a total shareholder equity of DKK498.7M and total debt of DKK1.1M, which brings its debt-to-equity ratio to 0.2%. Its total assets and total liabilities are DKK593.5M and DKK94.8M respectively. ChemoMetec's EBIT is DKK180.4M making its interest coverage ratio -39.6. It has cash and short-term investments of DKK232.2M.
Key information
0.2%
Debt to equity ratio
kr.1.11m
Debt
| Interest coverage ratio | -39.6x |
| Cash | kr.232.15m |
| Equity | kr.498.73m |
| Total liabilities | kr.94.78m |
| Total assets | kr.593.51m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: CHY's short term assets (DKK420.6M) exceed its short term liabilities (DKK89.9M).
Long Term Liabilities: CHY's short term assets (DKK420.6M) exceed its long term liabilities (DKK4.9M).
Debt to Equity History and Analysis
Debt Level: CHY has more cash than its total debt.
Reducing Debt: CHY's debt to equity ratio has reduced from 22.5% to 0.2% over the past 5 years.
Debt Coverage: CHY's debt is well covered by operating cash flow (13193.6%).
Interest Coverage: CHY earns more interest than it pays, so coverage of interest payments is not a concern.